Treatment Refusal: Clinical Trials

2 trials for Treatment Refusal, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Terminated 1, Unknown 1

Follow Treatment Refusal: new trials by email Literature Review of Treatment Refusal trials Research Report on Treatment Refusal

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PEG-ASP, Etoposide and Gemcitabine for Natural Killer/T Lymphoma
Gemcitabine, etoposide, Pegaspargase - Treatment Refusal
Phase 2UnknownSun Yat-sen University352016-02-012023-06-18
"Sandwich" Chemotherapy With Radiotherapy in Newly Diagnosed, Stage IE to IIE, ENKTL
P-CHOP, Radiotherapy - Treatment Refusal
Phase 2TerminatedSun Yat-sen University122013-06-012018-05-09

Broader conditions

Behavior (2)  ·  Health Behavior (2)  ·  Treatment Adherence and Compliance (2)

Interventions

pegaspargase (2)  ·  Etoposide (1)  ·  Gemcitabine (1)  ·  Radiotherapy (1)  ·  etoposide phosphate (1)

Sponsors

Sun Yat-sen University (2)

Countries

China (2)

Results publications

PMID 39268981